Steris PLC (Ireland) (STE) closed at $257.12 on November 10, 2026, up 0.1% from the previous close, on volume of 739,427 shares (30-day average 749,860).
Data as of November 10, 2026.
10-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Nov 3, 2026 | Put Spread | 20-Nov-26200 : 220 P | 1,000 |
| 2-2 | The next 1 largest trades are for Premium members. Start a 7-day free trial | |||
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 9, 2026. See the 10 largest for 30, 60 and 90 days
UBS Remains a Buy on Steris (STE)
TipRanks (Fri, 6-Nov 10:03 AM ET)
Steris (STE) Gets a Buy from KeyBanc
TipRanks (Fri, 6-Nov 3:55 AM ET)
STERIS Announces Financial Results for Fiscal 2027 Second Quarter
Globe Newswire (Wed, 4-Nov 4:30 PM ET)
STERIS Announces Dividend of $0.69 per share
Globe Newswire (Wed, 28-Oct 4:30 PM ET)
CooperCompanies Announces Leadership Transition and Board Refreshment
Globe Newswire (Tue, 27-Oct 4:28 PM ET)
STERIS to Host a Conference Call for Fiscal 2027 Second Quarter on November 5, 2026
Globe Newswire (Tue, 20-Oct 4:30 PM ET)
Xodus Medical Announces Agreement to Be Acquired by STERIS (NYSE: STE)
PRNewswire (Mon, 12-Oct 2:45 PM ET)
Globe Newswire (Mon, 12-Oct 8:00 AM ET)
STERIS to Present at the Morgan Stanley Healthcare Conference
Globe Newswire (Tue, 1-Sep 4:30 PM ET)
STERIS Raises 2026 Outlook as Revenue Jumps 10% and Cash Flow Strengthens
Market Chameleon (Thu, 6-Nov 6:30 AM ET)
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 20% from Applied Sterilization Technologies, or AST, and 10% from life sciences services after the divestment of its dental products business.
Steris PLC (Ireland) trades on the NYSE stock market under the symbol STE.
As of November 10, 2026, STE stock price climbed to $257.12 with 739,427 million shares trading.
STE has a beta of -0.04, meaning it tends to be less sensitive to market movements. STE has a correlation of 0.00 to the broad based SPY ETF.
STE has a market cap of $24.97 billion. This is considered a Large Cap stock.
Last quarter Steris PLC (Ireland) reported $2 billion in Revenue and $2.94 earnings per share. This beat revenue expectation by $28 million and exceeded earnings estimates by $.26.
In the last 3 years, STE traded as high as $269.44 and as low as $195.14.
The top ETF exchange traded funds that STE belongs to (by Net Assets): VTI, VOO, VO, IVV, SPY.
STE has underperformed the market in the last year with a return of -1.5%, while SPY returned +12.9%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in STE shares. However, STE has outperformed the market in the last 3 month and 2 week periods, returning +8.6% and +11.7%, while SPY returned -2.8% and -2.0%, respectively. This indicates STE has been having a stronger performance recently.
STE support price is $252.52 and resistance is $261.36 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that STE shares will trade within this expected range on the day.
